Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01487811 · ClinicalTrials.gov registry record · Phase 1
Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers
A Phase 1 study, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT01487811 is a Phase 1 study that has completed, run by Novo Nordisk A/S. The registered enrollment target is 50 participants.
The verdict
NCT01487811, a Phase 1 study, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
This trial is conducted in the United states of America (USA). The aim of this trial is to compare two formulations of biphasic insulin aspart 30 in healthy volunteers.
Interventions
- DRUG biphasic insulin aspart 30
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2005-05 |
| Est. Completion | 2005-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01487811
The ClinicalTrials.gov registry entry for NCT01487811 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which biphasic insulin aspart 30 is the first listed.
NCT01487811 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01487811 about?
NCT01487811 is a clinical study titled "Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers". This trial is conducted in the United states of America (USA). The aim of this trial is to compare two formulations of biphasic insulin aspart 30 in healthy volunteers.
What is the current status of trial NCT01487811?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2005-05. Estimated completion is 2005-11.
What interventions are being tested in trial NCT01487811?
The interventions under investigation include: biphasic insulin aspart 30 (DRUG).
Who is sponsoring clinical trial NCT01487811?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.